FiercePharma

Long-Term Study Demonstrates Safety and Efficacy of SYMBICORT® in African American Patients with Asthma

DENVER--(BUSINESS WIRE)-- AstraZeneca (NYSE:AZN) today announced results from a long-term study comparing SYMBICORT ® (budesonide/ formoterol fumarate dihydrate) Inhalation Aerosol 160/4.5 mcg with ...
FiercePharma

FDA Updates U.S. Product Labels for LABA-Containing Medications Including AstraZeneca's SYMBICORT

For patients with COPD, the approved dosage of SYMBICORT is 160/4.5 mcg, 2 inhalations twice daily. The most common adverse events greater than or equal to 3% reported in COPD clinical trials included ...
EurekAlert!

Data showed improved quality of life and patient satisfaction with SYMBICORT

Wilmington, DE – May 22, 2007 – New data demonstrated that the combination asthma therapy, SYMBICORT® (budesonide/formoterol fumarate dihydrate), led to ...
EurekAlert!

Data show significant asthma control and improved lung function with Symbicort

Wilmington, DE – February 24, 2007 – New data demonstrated the maintenance combination asthma therapy, SYMBICORT® (budesonide/formoterol fumarate dehydrate ...
Business Wire

US FDA Updates SYMBICORT Label with LABA Safety Class Revisions and Removes Boxed WARNING for Serious Asthma-Related Outcomes

WILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca today announced the U.S. Food and Drug Administration (FDA) has approved updates to the SYMBICORT ® (budesonide ...
Business Wire

SYMBICORT Real-World Study Results Published in the International Journal of COPD

WILMINGTON, Del.--(BUSINESS WIRE)--Results from a US comparative effectiveness study of two maintenance treatment options for patients with a history of chronic obstructive pulmonary disease (COPD) ...
Medscape

FDA OKs Symbicort for Uncontrolled Asthma in Kids 6 to 12

The US Food and Drug Administration has approved AstraZeneca's Symbicort inhalation aerosol (80/4.5 mcg) for children aged 6 to 12 years with asthma that is not well controlled with an inhaled ...
Medindia

Newly Released Data on Onset of Effect and Patient Perception With SYMBICORT in Adults With Asthma

WILMINGTON, Del., Sept. 10 Newly releasedresults from two previously published studies demonstrated patients receivingthe maintenance combination asthma therapy ...
Nasdaq

FDA Approves First Generic Of Symbicort To Treat Asthma, COPD

(RTTNews) - The U.S. Food and Drug Administration approved Mylan Pharmaceuticals, Inc.'s generic of Symbicort (budesonide and formoterol fumarate dihydrate) inhalation aerosol. It is the first FDA- ...
MarketWatch

AstraZeneca says Symbicort approved by FDA for COPD

LONDON (MarketWatch) -- Drugmaker AstraZeneca said Monday that the U.S. Food and Drug Administration has approved Symbicort 160/4.5 mcg for the twice daily maintenance treatment of airflow obstruction ...